Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Kemper board director Kathleen Cronin passes away

EditorNatashya Angelica
Published 05/03/2024, 22:34
Updated 05/03/2024, 22:34
© Reuters.

CHICAGO - Kemper Corporation (NYSE: NYSE:KMPR), a leading specialized insurer, announced the passing of board member Kathleen M. Cronin on Sunday due to an extended illness. Cronin had been a part of Kemper's Board since February 2015, contributing significantly through her service on various board committees.

Cronin's career spanned several decades, marked by her roles as Senior Managing Director, General Counsel, and Corporate Secretary at CME Group Inc. (NASDAQ:CME), as well as her time as counsel at the law firm Skadden, Arps, Slate, Meagher & Flom. Her expertise in corporate law and governance was a valuable asset to the organizations she served.

Kemper's President, CEO, and Chairman, Joseph P. Lacher, Jr., expressed the company's sorrow over Cronin's passing, stating, "Kathleen was a meaningful contributor to our Board, and we're deeply saddened at her passing. She was truly a great person and we're honored to have had the opportunity to be associated with her. We will miss Kathleen's advice, wit, insight, and wise counsel, and our deepest condolences go out to her family during this time."

The Kemper family of companies, with approximately $13 billion in assets, provides personalized insurance solutions to individuals, families, and businesses through its Kemper Auto and Kemper Life brands. The company serves over 4.9 million policyholders and employs 8,100 associates who are dedicated to meeting the evolving needs of its customers.

This news is based on a press release statement from Kemper Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.